Holen Sie sich die Stockscreener-App
11.88
2.78%
-0.34
Handel nachbörslich:
11.47
-0.41
-3.45%
Schlusskurs vom Vortag:
$12.22
Offen:
$12.06
24-Stunden-Volumen:
634.02K
Relative Volume:
1.00
Marktkapitalisierung:
$804.85M
Einnahmen:
$568.09M
Nettoeinkommen (Verlust:
$27.27M
KGV:
36.26
EPS:
0.3276
Netto-Cashflow:
$71.41M
1W Leistung:
+13.36%
1M Leistung:
+31.27%
6M Leistung:
+47.95%
1J Leistung:
+60.76%
1-Tages-Spanne:
$11.58
$12.08
1-Wochen-Bereich:
$10.49
$12.30
52-Wochen-Spanne:
$5.81
$12.30
Bioventus Inc Stock (BVS) Company Profile
Firmenname
Bioventus Inc
Sektor
Branche
Telefon
(919) 474-6700
Adresse
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Compare BVS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
11.88 | 804.85M | 568.09M | 27.27M | 71.41M | 0.3276 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | CJS Securities | Market Outperform |
| 2026-02-09 | Eingeleitet | Barrington Research | Outperform |
| 2025-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-12-07 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | Hochstufung | Craig Hallum | Hold → Buy |
| 2022-11-22 | Herabstufung | Craig Hallum | Buy → Hold |
| 2022-11-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-03-15 | Eingeleitet | Craig Hallum | Buy |
| 2021-11-15 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-11-10 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-01 | Herabstufung | Goldman | Buy → Neutral |
| 2021-03-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-08 | Eingeleitet | Goldman | Buy |
| 2021-03-08 | Eingeleitet | JP Morgan | Overweight |
| 2021-03-08 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioventus Inc Aktie (BVS) Neueste Nachrichten
Bioventus (BVS) Stock Looks Overvalued On Earnings Yet Backed By Broader Checks - Yahoo Finance
Bioventus, Inc. Class A Actuals & Estimates (LSX:A2APNA) - TradingView
Are You Looking for a Top Momentum Pick? Why Bioventus (BVS) is a Great Choice - Yahoo Finance
Craig-Hallum Maintains Bioventus(BVS.US) With Buy Rating, Announces Target Price $16 - Moomoo
Wall Street Analysts Predict a 28.81% Upside in Bioventus (BVS): Here's What You Should Know - Yahoo Finance
Bioventus Deadline Alert - TMX Newsfile
A2APNA Forecast — Price Target — Prediction for 2027 - TradingView
A2APNA Stock Price and Chart — LSX:A2APNA - TradingView
Bioventus: I See A Better Business Trading At A Fair Price (Upgrade) (NASDAQ:BVS) - Seeking Alpha
BioventusTargeting Earnings Growth Outpacing Revenue Growth In 2026 - RTTNews
Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Zacks.com featured highlights include First Advantage, Bioventus and Ooma - Yahoo Finance
Bioventus shares rise after Medicare reverses reimbursement cuts By Investing.com - Investing.com South Africa
Bioventus shares rise after Medicare reverses reimbursement cuts - Investing.com
Bioventus Shareholder Action Reminder - TMX Newsfile
Total liabilities of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Free cash flow of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Cash flow from investing activities of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Net debt of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Non-operating income (total) of Bioventus, Inc. Class A – LS:A2APNA - TradingView
EBIT of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Cash flow from operating activities of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Operating income of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Preferred dividends of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Bioventus, Inc. Class A Cash Flow – LS:A2APNA - TradingView
Non-controlling/minority interest of Bioventus, Inc. Class A – LS:A2APNA - TradingView
EBITDA of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Debt to assets ratio of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Debt to equity ratio of Bioventus, Inc. Class A – LS:A2APNA - TradingView
EBIT per share of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Price to earnings forward of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Enterprise value to EBITDA forward of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Return on equity % of Bioventus, Inc. Class A – LS:A2APNA - TradingView
CapEx per share of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Net current asset value per share of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Enterprise value of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Net margin % of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Enterprise value to EBITDA ratio of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Inventory turnover of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Enterprise value to EBIT forward of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Price to cash flow ratio of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Diluted shares outstanding of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Return on invested capital % of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Total debt per share of Bioventus, Inc. Class A – LS:A2APNA - TradingView
EBITDA margin % of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Quick ratio of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Diluted earnings per share (diluted EPS) of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Net income before discontinued operations of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Bioventus, Inc. Class A Dividends – LS:A2APNA - TradingView
Cost of goods sold of Bioventus, Inc. Class A – LS:A2APNA - TradingView
Bioventus, Inc. Class A Earnings and Revenue – LS:A2APNA - TradingView
Finanzdaten der Bioventus Inc-Aktie (BVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):